Oscar Health, Inc. (NYSE:OSCR) Q2 2022 Earnings Conference Call August 11, 2022 5:00 PM ET

Company Participants

Cornelia Miller - Vice President of Corporate Development & Investor Relations

Mario Schlosser - Co-Founder & Chief Executive Officer

Scott Blackley - Chief Financial Officer

Conference Call Participants

Michael Hall - Morgan Stanley

Stephen Baxter - Wells Fargo Securities

Jonathan Yong - Credit Suisse

Kevin Fischbeck - Bank of America

Josh Raskin - Nephron Research

Lindsay Golub - Goldman Sachs

Operator

Good afternoon. My name is Christian and I will be your conference operator today. At this time, I would like to welcome everyone to Oscar Health 2022 Second Quarter Conference Call. All lines have been placed on you to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions] Thank you.

I would now like to turn it over to Cornelia Miller, Vice President of Corporate Development and Investor Relations, to begin the conference.

Cornelia Miller

Thank you, Christian and good afternoon, everyone. Thank you for joining us for our second quarter 2022 earnings call, where we’ll walk through our results and our trajectory for the rest of the year. Mario Schlosser, Oscar’s Co-Founder and Chief Executive Officer, and Scott Blackley, Oscar’s Chief Financial Officer, will host this afternoon’s call, which can also be accessed through our Investor Relations website at ir.hioscar.com.

Full details of our results and additional management commentary are available in our earnings release, which can be found on our Investor Relations website at ir.hioscar.com. Any remarks that Oscar makes about the future constitute forward-looking statements within the meaning of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by those forward-looking statements as a result of various important factors including those discussed in our annual report on Form 10-Q for the quarterly period ended March 31, 2022, filed with the SEC and our other filings with the SEC, including our quarterly report on Form 10-Q for the quarterly period ended June 30, 2022, to be filed with the SEC. Such forward-looking statements are based on current expectations as of today.

Oscar anticipates that subsequent events and developments may cause estimates to change. While the company may elect to update these forward-looking statements at some point in the future, we specifically disclaim any obligation to do so. This call will also refer to certain non-GAAP measures. A reconciliation of these measures to the most directly comparable GAAP measures can be found in our second quarter 2022 press release, which is available on the company’s Investor Relations website at ir.hioscar.com.